Efficacy investigation of combination therapy with Alprostadil Lipo preparation and enoxaprian in acute coronary syndrome
10.3760/cma.j.issn.1008-6706.2010.23.032
- VernacularTitle:前列地尔联合肝素钠治疗急性冠脉综合征疗效观察
- Author:
Wenhua XU
- Publication Type:Journal Article
- Keywords:
Alprostadil Heparin;
Coronary syndrome
- From:
Chinese Journal of Primary Medicine and Pharmacy
2010;17(23):3229-3230
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficacy of combination therapy with alprostadil Lipo preparation (lipo-pge1)and enoxaprian in patients with acute coronary syndrome(ACS). MethodsA total of 60 ACS patients were randomly divided into two groups.The therapy group were treated with ASA,nitrates,statins,enoxaprian and alprostadil 10 days for a course,the control group were treated with ASA,nitrates,statins and enoxaprian 10 days for a course.Clinical symptoms,ECG changes,blood lipid changes were measured before and after treatments. ResultsThe total effective rate of the therapy group and control group in-patient treatment within 10 days were 96.7% and 83.3%(P＜0.01).The remission rate of angina pectoris,improvement rate of ECG changes and lipid levers were better in therapy group than those in control group(all P＜0.01). ConclusionIt was effective to use Alprostadil Lipo agent combination with enoxaprian in treatment of ACS.
